<DOC>
	<DOCNO>NCT01913379</DOCNO>
	<brief_summary>A study ass possible drug-drug interaction MDV3100 gemfibrozil MDV3100 Itraconazole .</brief_summary>
	<brief_title>Drug-drug Interaction Study With MDV3100 ( ASP9785 ) Gemfibrozil Itraconazole</brief_title>
	<detailed_description />
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<mesh_term>Gemfibrozil</mesh_term>
	<criteria>Body weight least 65.0 kg great 85.0 kg . Body Mass Index ( BMI ) least 18.5 great 30.0 kg/m2 . Known suspected hypersensitivity MDV3100 , itraconazole , gemfibrozil , component formulation use , history liver toxicity drug . Confirmed CYP2C8 PM status base genotyping analysis . Any liver function test upper limit normal . A retest confirm result may perform . History seizure , include febrile seizure , loss consciousness , transient ischemia attack within 12 month prior enrollment ( Day 1 visit ) , condition may predispose seizure ( e.g. , prior stroke , brain arteriovenous malformation , head trauma loss consciousness require hospitalization ) . Any clinically significant history asthma , eczema , allergic condition previous severe hypersensitivity drug ( exclude nonactive hay fever ) . Abnormal pulse and/or blood pressure ( BP ) measurement prestudy visit follow : Pulse &lt; 40 &gt; 90 bpm ; mean systolic BP &gt; 140 mmHg ; mean diastolic BP &gt; 90 mmHg ( BP measurement take triplicate subject rest supine position 5 min ; pulse measure automatically ) . A QTc interval &gt; 430 m repeat measurement ( consistently duplicate measurement ) , history unexplained syncope , cardiac arrest , unexplained cardiac arrhythmia torsades de pointes , structural heart disease , family history Long QT Syndrome ( LQTS ) . Regular use inducer metabolism ( e.g . barbiturate , rifampin ) 3 month prior admission Clinical Unit . Positive serology test HBsAg , anti HAV ( IgM ) , antiHCV antiHIV 1+2 .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>MDV3100</keyword>
	<keyword>Gemfibrozil</keyword>
	<keyword>Itraconazole</keyword>
	<keyword>Xtandi</keyword>
	<keyword>enzalutamide</keyword>
</DOC>